Compile Data Set for Download or QSAR
Report error Found 16 Enz. Inhib. hit(s) with all data for entry = 50038021
TargetGlycogen synthase kinase-3 beta(Human)
Johnson & Johnson Pharmaceutical Research & Development

Curated by ChEMBL
LigandPNGBDBM50371215(CHEMBL1162963)
Affinity DataIC50: 3nMAssay Description:Inhibition of human recombinant GSK3-betaMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/13/2012
Entry Details Article
PubMed
TargetGlycogen synthase kinase-3 beta(Human)
Johnson & Johnson Pharmaceutical Research & Development

Curated by ChEMBL
LigandPNGBDBM50207805(20-(dimethylamino)-4,14,19,26-tetraazaheptacyclo[2...)
Affinity DataIC50: 7nMAssay Description:Inhibition of human recombinant GSK3-betaMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/13/2012
Entry Details Article
PubMed
TargetGlycogen synthase kinase-3 beta(Human)
Johnson & Johnson Pharmaceutical Research & Development

Curated by ChEMBL
LigandPNGBDBM50207804(20-(pyrrolidin-1-yl)-4,14,19,26-tetraazaheptacyclo...)
Affinity DataIC50: 11nMAssay Description:Inhibition of human recombinant GSK3-betaMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/13/2012
Entry Details Article
PubMed
TargetGlycogen synthase kinase-3 beta(Human)
Johnson & Johnson Pharmaceutical Research & Development

Curated by ChEMBL
LigandPNGBDBM50207808(33-(pyrrolidin-1-yl)-6,16,26,32-tetraazaheptacyclo...)
Affinity DataIC50: 24nMAssay Description:Inhibition of human recombinant GSK3-betaMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/13/2012
Entry Details Article
PubMed
TargetGlycogen synthase kinase-3 beta(Human)
Johnson & Johnson Pharmaceutical Research & Development

Curated by ChEMBL
LigandPNGBDBM50207807(31-(pyrrolidin-1-yl)-5,15,25,30-tetraazaheptacyclo...)
Affinity DataIC50: 30nMAssay Description:Inhibition of human recombinant GSK3-betaMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/13/2012
Entry Details Article
PubMed
TargetGlycogen synthase kinase-3 beta(Human)
Johnson & Johnson Pharmaceutical Research & Development

Curated by ChEMBL
LigandPNGBDBM50207806(31-(dimethylamino)-5,15,25,30-tetraazaheptacyclo[2...)
Affinity DataIC50: 37nMAssay Description:Inhibition of human recombinant GSK3-betaMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/13/2012
Entry Details Article
PubMed
TargetRibosomal protein S6 kinase alpha-3(Human)
Johnson & Johnson Pharmaceutical Research & Development

Curated by ChEMBL
LigandPNGBDBM50371215(CHEMBL1162963)
Affinity DataIC50: 48nMAssay Description:Inhibition of human Rsk3More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/13/2012
Entry Details Article
PubMed
TargetProtein kinase C theta type(Human)
Johnson & Johnson Pharmaceutical Research & Development

Curated by ChEMBL
LigandPNGBDBM50371215(CHEMBL1162963)
Affinity DataIC50: 98nMAssay Description:Inhibition of human PKCthetaMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/13/2012
Entry Details Article
PubMed
TargetRibosomal protein S6 kinase alpha-5(Human)
Johnson & Johnson Pharmaceutical Research & Development

Curated by ChEMBL
LigandPNGBDBM50371215(CHEMBL1162963)
Affinity DataIC50: 510nMAssay Description:Inhibition of human MSK1More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/13/2012
Entry Details Article
PubMed
TargetRibosomal protein S6 kinase alpha-2(Human)
Johnson & Johnson Pharmaceutical Research & Development

Curated by ChEMBL
LigandPNGBDBM50371215(CHEMBL1162963)
Affinity DataIC50: 850nMAssay Description:Inhibition of human Rsk2More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/13/2012
Entry Details Article
PubMed
TargetProtein kinase C beta type(Human)
Johnson & Johnson Pharmaceutical Research & Development

Curated by ChEMBL
LigandPNGBDBM50207804(20-(pyrrolidin-1-yl)-4,14,19,26-tetraazaheptacyclo...)
Affinity DataIC50: 1.20E+3nMAssay Description:Inhibition of human recombinant PKCbeta2More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/13/2012
Entry Details Article
PubMed
TargetProtein kinase C beta type(Human)
Johnson & Johnson Pharmaceutical Research & Development

Curated by ChEMBL
LigandPNGBDBM50371215(CHEMBL1162963)
Affinity DataIC50: 1.40E+3nMAssay Description:Inhibition of human recombinant PKCbeta2More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/13/2012
Entry Details Article
PubMed
TargetRibosomal protein S6 kinase alpha-1(Human)
Johnson & Johnson Pharmaceutical Research & Development

Curated by ChEMBL
LigandPNGBDBM50371215(CHEMBL1162963)
Affinity DataIC50: 1.90E+3nMAssay Description:Inhibition of human Rsk1More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/13/2012
Entry Details Article
PubMed
TargetProtein kinase C beta type(Human)
Johnson & Johnson Pharmaceutical Research & Development

Curated by ChEMBL
LigandPNGBDBM50207807(31-(pyrrolidin-1-yl)-5,15,25,30-tetraazaheptacyclo...)
Affinity DataIC50: 2.20E+3nMAssay Description:Inhibition of human recombinant PKCbeta2More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/13/2012
Entry Details Article
PubMed
TargetProtein kinase C beta type(Human)
Johnson & Johnson Pharmaceutical Research & Development

Curated by ChEMBL
LigandPNGBDBM50207805(20-(dimethylamino)-4,14,19,26-tetraazaheptacyclo[2...)
Affinity DataIC50: 2.40E+3nMAssay Description:Inhibition of human recombinant PKCbeta2More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/13/2012
Entry Details Article
PubMed
TargetBDNF/NT-3 growth factors receptor(Human)
Johnson & Johnson Pharmaceutical Research & Development

Curated by ChEMBL
LigandPNGBDBM50371215(CHEMBL1162963)
Affinity DataIC50: 3.00E+3nMAssay Description:Inhibition of human TrkBMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/13/2012
Entry Details Article
PubMed